伝統医薬データベース　

サイト内検索結果「」

全16,951件中、3,381件～3,400件を表示しています。
[1] ・・・ [165] [166] [167] [168] [169] [170] [171] [172] [173] [174] [175] ・・・ [848]

6761. [生薬成分の代謝] 代謝パラメータ『Oral administration 』

Oral administration 50 mg/kg N.D. N.D. N.D. 0-10 h N.D. : not detected. Saikosaponin b1 代謝パラメータ

7-hydroxy-3-(4-hydroxyphenyl)-4H-chromen-4-one Daidzein 486-66-8 C15H10O4 254.242 254.0579 255.0657 253.0501 Daidzein 代謝物

6763. [生薬成分の代謝] 代謝パラメータ『Oral administration』

Oral administration 4.81 ± 0.41 h 1.0 ± 0.3 h 216.5 ± 61.6 ng/mL 1093.3 ± 371.0 ng/mLxh 1104.9 ± 369.4 ng/mLxh 0-t 0― Geniposide 代謝パラメータ

6764. [生薬成分の代謝] 代謝パラメータ『Intravenous administration』

Intravenous administration 50 mg/kg (n=5) 83.3 ± 64.3 21.0 ± 13.4 min 23.5  7.6 ng/mL 2.05 ± 1.15 μg・min/mL Ae0-24h0.036 ± 0.039 % of dose GI24h0.08 ± 0.002 % of dose F 0.3 % Verprosi

6765. [生薬成分の代謝] 代謝物『Harpagoside』

(1S,4aS,5R,7S,7aS)-4a,5-dihydroxy-7-methyl-1-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-1,4a,5,6,7,7a-hexahydrocyclopenta[c]pyran-7-yl cinnamate Harpagoside 192

6766. [生薬成分の代謝] 代謝物『Lithospermic acid B』

(R)-2-(((2S,3S)-4-((E)-3-((R)-1-carboxy-2-(3,4-dihydroxyphenyl)ethoxy)-3-oxoprop-1-en-1-yl)-2-(3,4-dihydroxyphenyl)-7-hydroxy-2,3-dihydrobenzofuran-3-carbonyl)oxy)-3-(3,4-dihydroxyphenyl)propanoic aci

6767. [生薬成分の代謝] 代謝物『Shikometabolin A』

(R)-1,4,6,7,10-pentahydroxy-3-(1-hydroxy-4-methylpent-3-en-1-yl)-12-(3-methylbut-2-en-1-yl)-5H-dibenzo[b,h]fluorene-5,11,13-trione Shikometabolin A 154277-76-6 C32H28O9 556.569 556.1733 557.1812 555.1

6768. [生薬成分の代謝] 代謝物『(-)-Arctigenin』

(3R,4R)-4-(3,4-dimethoxybenzyl)-3-(4-hydroxy-3-methoxybenzyl)dihydrofuran-2(3H)-one (-)-Arctigenin 7770-78-7 C21H24O6 372.418 372.1573 373.1651 371.1495 Arctigenin 代謝物

6769. [生薬成分の代謝] 代謝物『Baicalin』

(2S,3S,5R)-6-((5,6-dihydroxy-4-oxo-2-phenyl-4H-chromen-7-yl)oxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic acid Baicalin 21967-41-9 C21H18O11 446.367 446.0849 447.0927 445.0771 Baicalin 代謝物

6770. [生薬成分の代謝] 代謝物『Magnolol』

5,5'-diallyl-[1,1'-biphenyl]-2,2'-diol Magnolol 528-43-8 C18H18O2 266.34 266.1307 267.1385 265.1229 Magnolol 代謝物

6771. [生薬成分の代謝] 代謝物『Oxypaeoniflorin』

((2S,2aR,2a1S,3aR,4R,5aR)-4-hydroxy-2-methyl-2a-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)hexahydro-2H-1,5-dioxa-2,4-methanocyclobuta[cd]pentalen-2a1-yl)methyl

6772. [生薬成分の代謝] 代謝物『Paeonimetabolin I』

(2S,3aR,5R,7aS)-3a-hydroxy-7a,8-dimethyltetrahydro-2,5-methanobenzo[d][1,3]dioxol-6(3aH)-one Paeonimetabolin I 99624-67-6 C10H14O4 198.219 198.0892 199.097 197.0814 Oxypaeoniflorin 代謝物

6773. [生薬成分の代謝] 代謝パラメータ『Oral administration』

Oral administration 40 mg/kg 1.16 ± 1.0 h ^a 144.3 ± 93.2 ng∙h∙ml^-1 ^a 0-limit 2.68 ± 1.5 h ^a 0.35 ± 0.2 h a p< 0.05, b p< 0.01 compared with conventional rats; Data are expressed as m

6774. [生薬成分の代謝] 代謝物『Paeoniflorin』

((2S,2aR,2a1S,3aR,4R,5aR)-4-hydroxy-2-methyl-2a-(((2R,3R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)hexahydro-2H-1,5-dioxa-2,4-methanocyclobuta[cd]pentalen-2a1-yl)methyl ben

6775. [生薬成分の代謝] 代謝物『10-Hydroxyaloin A (10R)』

1,8,10-trihydroxy-3-(hydroxymethyl)-10-((2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)anthracen-9(10H)-one 10-Hydroxyaloin A (10R) C21H22O10 434.4 434.1213 435.1291 433.

6776. [生薬成分の代謝] 代謝物『Rheinoside A』

4,9-dihydroxy-10-oxo-9-((2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)-5-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-9,10-dihydroan

6777. [生薬成分の代謝] 代謝物『Rheinoside C』

4-hydroxy-10-oxo-9-((2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)-5-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-9,10-dihydroanthra

6778. [生薬成分の代謝] 代謝物『Saikosaponin a』

(2S,3R,4S,5S,6R)-2-(((2R,3R,4S,5S,6R)-3,5-dihydroxy-2-(((3S,4R,6aR,6bS,8R,8aS,12bS,14bR)-8-hydroxy-4-(hydroxymethyl)-4,6a,6b,11,11,14b-hexamethylicosahydro-12b,8a-(epoxymethano)picen-3-yl)oxy)-6-methy

6779. [生薬成分の代謝] 代謝物『Saikosaponin b1』

(2S,3R,4S,5S,6R)-2-(((2R,3R,4S,5S,6R)-3,5-dihydroxy-2-(((3S,4R,6aR,6bS,8R,8aS,14bS)-8-hydroxy-4,8a-bis(hydroxymethyl)-4,6a,6b,11,11,14b-hexamethyl-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,14a,14b-octade

6780. [生薬成分の代謝] 代謝物『Saikosaponin b2』

(2S,3R,4S,5S,6R)-2-(((2R,3R,4S,5S,6R)-3,5-dihydroxy-2-(((3S,4R,6aR,6bS,8S,8aS,14bS)-8-hydroxy-4,8a-bis(hydroxymethyl)-4,6a,6b,11,11,14b-hexamethyl-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,14a,14b-octade

[1] ・・・ [165] [166] [167] [168] [169] [170] [171] [172] [173] [174] [175] ・・・ [848]
全16,951件中、3,381件～3,400件を表示しています。

ページの上へ戻る

TOPICS

生薬

漢方

試験薬物

遺伝子解析情報

化学分析情報

活性試験情報

生薬成分の代謝情報

探索研究